Agilent Names McMullen as CEO and Creates New Business
Mr. McMullen will continue to serve as acting president of CAG for the near term, according to an Agilent spokesperson. He has been with Agilent since 1984 and was named president of CAG in 2009. Mr. Sullivan has been president and CEO of Agilent since 2005. He will serve as an advisor until October 31, 2015. The new Agilent CrossLab Group includes consumables and services from both the CAG and Life Sciences Group. Pathology consumables and services remain within the Diagnostics Group
Santa Clara, CA 9/17/14; Santa Clara, CA 9/17/14; Santa Clara, CA 9/17/14—Agilent Technologies has announced that Mike McMullen, senior vice president and president of the Chemical Analysis Group (CAG), will succeed William Sullivan as CEO on March 18, 2015. Agilent has appointed Mr. McMullen president and COO, effective immediately. “Agilent’s re-launch is the perfect time to begin the CEO transition. Mike is an excellent choice to lead the company,” commented Mr. Sullivan. “He transformed CAG, reshaping its portfolio and championing key acquisitions that have resulted in a consistent, market-leading record of profitable growth.” Agilent also announced the creation of Agilent CrossLab Group, a new services and consumables organization, and named Mark Doak as its president. Mr. Doak had been senior vice president and general manager of the Services and Support Division. The new Group unifies Agilent’s CrossLab Services and Consumables initiatives. The changes were announced the same day that Agilent’s Board approved the spin-off of Keysight Technologies, the company’s electronic measurement subsidiary (see IBO 9/30/14) and declared a special dividend distribution of shares of Keysight stock to Agilent shareholders. Keysight will begin trading on the NYSE on November 3, and Agilent will have no ownership in the company.
